World March 13, 2023
By Dr. Charles Hurbis

Where things become almost comical is drug pricing. New drugs are introduced with nosebleed level prices, while old drugs are often relabeled, re-dosed and then remarketed with hugely inflated prices. Drug companies price drugs at, “whatever the market will bear” levels. Medications at times have their prices change exponentially. I’ll use examples from within my medical specialty.

Bear in mind here that during these pricing follies the supplied product never changes. A standard neomycin/polymyxin ear drop perhaps 20 years ago sold for maybe $20 per bottle. There is nothing fancy here. It is effective but contains a combination of very old medications. Due to an unfavorable study on this medication a few years back prices dropped to...

Today's Sponsors

Upfront Healthcare

Today's Sponsor


Topics: Biotechnology, Employer, Govt Agencies, Healthcare System, Insurance, Medical Devices, Patient / Consumer, Payment Models, Pharma, Pharma / Biotech, Provider
Can artificial intelligence provide evidence-based responses to public health questions?
The public health emergency is over. Here’s why government must prioritize funding for long COVID research.
Visualized: The 4 Billion Year Path of Human Evolution
Taking Stock Of US Healthcare And Its Leadership Dilemma
Getting Cancer Drugs To The Right Patients At The Right Time

Share This Article